#phrma — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #phrma, aggregated by home.social.
-
#TrumpCoup #TreasuryTakeover #Musk
UPDATE
*#BusinessInsider has procured a list of the (so far) 30 people working for #CoPresident #Musk's #DOGE*
(14/n)
... who #Musk hired as an advisor over the summer to help his get-out-the-vote work, was most recently a senior political advisor at #PhRMA, a trade association that advocates on behalf of pharmaceutical companies. He was previously a national field director for the #RepublicanNationalCommittee
-
Big-name drugs see price drops in first round of Medicare negotiations - Enlarge / Prescription drugs are displayed at NYC Discount Pharmacy in ... - https://arstechnica.com/?p=2043687 #pharmaceuticalindustry #pricenegotiations #drugprices #bigpharma #medicare #science #health #phrma
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Big Pharma is “coming to the table” on price negotiations as it loses in court - Enlarge (credit: Getty | Bodo Marks)
Federal health officials ... - https://arstechnica.com/?p=2008311 #pharmaceuticalindustry #pricenegotiations #astrazeneca #drugpricing #medicare #science #health #phrma
-
Federal #court in #Texas dismissed #lawsuit brought by heavy-hitting #pharmaceutical trade group, #PhRMA, which argued forcing #drug makers to negotiate #Medicare #drugprices is #unconstitutional. The big pharmaceutical companies suing government directly over negotiations include J&J, #BristolMyersSquibb, #NovoNordisk, #Merck, and #AstraZeneca. District Judge David Ezra found they first need to bring claims through an administrative review process under the #MedicareAct https://arstechnica.com/science/2024/02/judge-tosses-big-pharma-suit-claiming-drug-price-negotiation-is-unconstitutional/
-
Judge tosses Big Pharma suit claiming drug price negotiation is unconstitutional - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2003073 #pharmaceuticalindustry #astrazeneca #drugpricing #medicare #science #health #phrma
-
Big Pharma fought drug pricing reform with record $7.5M dark money donation - Enlarge (credit: Getty | YinYang)
In August, the Department of... - https://arstechnica.com/?p=1986148 #pharmaceuticalindustry #drugpricenegotiations #inflationreductionact #drugpricingreform #drugpricing #darkmoney #science #health #phrma #gop
-
#PhRMA suing the US government to block enforcement of a program giving #Medicare power to negotiate drug prices. https://www.phrma.org/resource-center/Topics/Access-to-Medicines/Release-NICA-GCCA-PhRMA-Litigation-Asserts-Price-Setting-Provisions-in-the-Inflation-Reduction-Act-are-Unconstitutional
-
A broad diversity of patient advocacy groups have expressed alarm at Judge Kacsmaryk's unprecedented decision
“The implications of this ruling go far beyond #mifepristone,” read a statement of opposition signed by 30 organizations representing those with serious health conditions.
They warned, “If this judge’s ruling is allowed to stand, patients may no longer have the security of knowing that determinations about drug safety ultimately lie with the experts.”
Also objecting are pharmaceutical companies that recognize the threat to innovation posed by arbitrary judicial orders.
The interim director of the biotech organization #BIO described the decision as **an assault on science**, while the pharmaceutical organization #PhRMA expressed **serious concerns with any court substituting its opinion for the FDA’s expert approval decision-making**
